INSIGHTS ON LIQUID DOSE MANUFACTURING
-
Enhancing Biological Indicators With Enzyme Indicators
Achieve greater process assurance in decontamination cycles. Combining traditional indicators with rapid, quantitative enzyme data reveals performance trends to optimize validation.
-
Stability Issues Unique To Liquid Injectables And How To Avoid Them
Liquid injectables face stability risks like oxidation, hydrolysis, aggregation, temperature shifts, and packaging effects, requiring early, rigorous formulation and process controls.
-
Solving The Silicone Challenge In Pre-Fillable Syringes
Discover a technology platform that is revolutionizing the pre-fillable syringe market by solving the challenge of silicone sensitivity, ensuring stability for sensitive drugs.
-
Commercially Proven Sterile Fill/Finish With Capacity And Global Backing
Find comprehensive solution with new sterile fill/finish investments supporting complex molecules through robust tech transfer, commercialization expertise, and integrated cGMP manufacturing solutions.
-
Cost-Effective Strategies For Sterile Injectable Outsourcing6/11/2025
Explore how CMOs are playing a pivotal role in enabling pharmaceutical companies to optimize their operations and how this collaboration is reshaping the future of pharmaceutical manufacturing.
-
Maintaining Cell Viability During The Cryovial Filling Process4/21/2025
Maintaining cell viability during cryovial filling is a critical challenge in cell therapy manufacturing. This presentation introduces cryoFIL®, a cutting-edge automated cryovial filling platform designed to deliver high-precision, aseptic, and scalable solutions for cryovial filling.
-
Formulation Development For Therapeutic Oligonucleotides6/10/2025
Discover how expert formulation and analytical support enable the development of stable, injectable oligonucleotide therapies across diverse delivery routes and molecule types.
-
Validating VH2O2 Decontamination Cycles For Product And Personnel Safety6/30/2026
Discover how ultra-sensitive spectroscopy transforms decontamination validation, revealing hidden efficiencies that safely cut facility downtime while ensuring absolute safety.
-
AST Origins: Pioneering RTU Flexibility With Robotic Fill-Finish Systems3/25/2026
Modernize sterile manufacturing with robotic fill-finish systems. Achieve multi-format flexibility and risk reduction to meet the rigorous demands of personalized medicine and small-batch production.
LIQUID DOSE MANUFACTURING SOLUTIONS
-
Used 200 liter Feldmeier reactor, 316L stainless steel construction, approximately 26" diameter x 25" straight side, removable dish top, dish bottom, rated 60 psi and full vacuum at 302 f internal, jacketed for 125 psi and full vacuum at 353 f, .75 hp bottom mounted agitator drive, 230/460 volt, serial# SO29512, national board# 4463, built 2012.
-
Our Rigid Stainless Steel Containment Isolators have been designed for handling potent compounds that can offer guaranteed levels of operator protection as low as 10ng/m3 (task duration). These include designs for sampling, dispensing and sub-division, mixing, milling and vessel charging, as well as containing integrated process devices such as filter dryer units, tablet press enclosures, blenders, mills and pack off systems.
-
Specialist in Aseptic Fill-Finish and packaging of Cartridges, pre-filled syringes (PFS) and vials.
-
Discover end-to-end containment solutions for bulk handling, isolator technology, and sterile processing that prioritize safety, efficiency, and innovation in hazardous material handling.
-
Discover how Cambrex can reliably develop and manufacture a broad spectrum of HPAPIs and compounds.